Shenkman Capital Management »

Biomarin Pharmaceutical shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $12B 12M 1041.12
2023-09-30 $237M 237k 1000.32
2023-06-30 $240M 237k 1011.90
2023-03-31 $250M 237k 1052.73
2022-12-31 $256M 237k 1081.16
2022-09-30 $238k 237k 1.00
2022-06-30 $237k 237k 1.00
2021-12-31 $3.0M 2.9M 1.05
2021-09-30 $18M 18M 1.01
2021-06-30 $15M 15M 1.01